GlassScriptPhysician profile
Jitender Munjal
NPI 1417077603
$65,757.19
in general payments reported to CMS, 2019-2025
41 companies · $19K in 2025
The $19K reported for 2025 was more than what 88% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $4,032 · 2021: $3,135 · 2022: $3,280 · 2023: $7,314 · 2024: $11K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Consulting Fee: $11K · Travel and Lodging: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,186.76 |
| Consulting Fee | $11,439.38 |
| Travel and Lodging | $10,237.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $34,387.14 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Boston Scientific Corporation | $9,802.81 | 2019-2025 | Farapulse, Latitude Communicator Power Supply, Emblem Mri S-Icd |
| Cvrx, INC. | $5,775.85 | 2020-2025 | Barostim Neo System |
| Biotronik INC. | $3,010.49 | 2019-2023 | Solia |
| Zoll Respicardia, INC. | $2,219.35 | 2020-2023 | Remede System |
| Philips North America LLC | $1,980.23 | 2019-2023 | |
| Medical Device Business Services, INC. | $1,611.24 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $1,527.61 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $699.50 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $617.14 | 2019-2025 | |
| Medtronic Vascular, INC. | $419.70 | 2019 | |
| Abbott Laboratories | $413.76 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $408.04 | 2021-2023 | Verquvo |
| Kestra Medical Technology Services, INC. | $329.87 | 2022-2024 | Assure Wcd |
| Pfizer INC. | $307.02 | 2022-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $240.07 | 2020-2024 | Impella |
| Acutus Medical, INC. | $236.92 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $211.91 | 2021-2023 | Optimizer |
| Medtronic, INC. | $191.60 | 2023 | Na |
| Recor Medical INC | $169.54 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cook Medical LLC | $148.70 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $140.08 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.97 | 2019-2025 | Jardiance |
| Inspire Medical Systems, INC. | $117.16 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $108.86 | 2019-2025 | Farxiga |
| Baxter Healthcare | $69.46 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Welch Allyn | $66.07 | 2021 | |
| Akcea Therapeutics, INC. | $59.57 | 2019 | |
| Stereotaxis INC | $50.66 | 2021-2023 | Niobe |
| Itamar Medical INC | $50.12 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $47.84 | 2022-2025 | Amvuttra |
| Kiniksa Pharmaceuticals International, Plc | $36.86 | 2024 | Arcalyst |
| Bardy Diagnostics, INC. | $30.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $28.87 | 2021-2022 | |
| Altathera Pharmaceuticals LLC | $22.01 | 2025 | Sotalol Hydrochloride |
| Cardiva Medical, INC. | $20.15 | 2024 | Ensoetm |
| Lexicon Pharmaceuticals, INC. | $18.18 | 2024 | |
| Esperion Therapeutics, INC. | $16.53 | 2022 | |
| Novo Nordisk INC | $16.33 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.27 | 2025 | |
| Amgen INC. | $12.71 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jitender Munjal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.